OSI Pharmaceuticals | Evaluate

November 13, 2014

As Intarcia's game plan plays out, what exit for investors?

January 29, 2014

As Xtandi Prevails, Medivation stays ahead of the curve

February 01, 2012

Average M&A deal values recover in 2011

February 17, 2011

Astellas taps into tivozanib's potential with billion-dollar deal

July 29, 2010

Allos leaves questions unanswered with Folotyn data

June 25, 2010

Sanofi snaffles novel diabetes drug

June 09, 2010

TransTech deal shows growing interest in GKA market

May 24, 2010

Asco look ahead - Big caps poised for slew of pivotal late stage data

May 17, 2010

OSI deal sees Astellas finally join its peers with a major overseas acquisition

April 26, 2010

Therapeutic focus - Sutent liver cancer failure leaves thin late-stage pipeline

April 19, 2010

OSI wins Tarceva label expansion, but Astellas unmoved

Load More